Bienvenido, invitado! | iniciar la sesión
US ES

Activity Stream

MoatRx
@moatrx3 weeks ago
Posted a new blog:
UK MYASTHENIA GRAVIS COMPETITIVE INTELLIGENCE
NICE rejected efgartigimod outright in 2025, leaving rozanolixizumab as the FcRn class's one still-untested bid for UK access. An estimated 7,000-10,000 UK...

Tags

Dislike 0
MoatRx
Seguidores:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recientemente clasificados:
estadísticas
Blogs: 120